2017 Mar 23 - Advances in neuroscience research utilizing modern in situ RNA gene expression techniques: Impressions from an early adopter of RNAscope
Dr. Jerold Chun, MD. Ph.D
Professor & Senior Vice President of Neuroscience Drug Discovery, Sanford Burnham Prebys Medical Discovery Institute
Outline:

in situ hybridization (ISH) has become the mainstay of many approaches to understanding gene expression in biology and pathology, whereby labelled probes complementary to mRNA sequences – i.e., anti-sense probes – are used to localize mRNAs in cells and tissue sections. In existence for some 5 decades, the basic ISH technique still requires substantial optimization covering a range of skills, from basic molecular biology to tissue isolation and preparation and is subject to further variability amongst operators. RNAscope offers a superior alternative and scalable approach to classical ISH, with recent iterations allowing resolution of much shorter targets and even junctional sequences. This webcast provides an introduction to this comparatively new commercial technology and its use in answering questions previously addressed by classical techniques. It is presented from the viewpoint of an ISH user with 30-years of classical experience who has switched to RNAscope and BaseScope, with a particular emphasis on its use in studying the nervous system. As a tangible example, the use of RNAscope was instrumental in validating “hits” identified from interrogating single-neuron transcriptomes obtained by sequencing single neuronal nuclei of the human brain (Science 352, 1586-1590 (2016)), and examples from this and other research efforts will be presented.

Learning Objectives:

In this webcast you will learn; advances in in situ hybridization and RNAscope enable RNA gene expression analysis off-the-shelf and single day assays BaseScope gene expression analysis enables splice variance and short target analysis mRNA analysis in neuroscience research where no antibodies are available; detection of long non-coding RNA (lncRNA) RNA-seq to target validation and validation of (cell type-specific) genetic modifications; and ability to visualize in situ expression of virtually any gene, any species and any tissue. You will also have the opportunity to ask questions of our speaker, live during the broadcast!

Dates and Registration:
March
23
10 AM PT
1 PM ET
5 PM GMT
6 PM CET
Register Now
X
Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

021-52293200
info.cn@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com